Skip to content

Left Ventricular Synchronous Versus Sequential MultiSpot Pacing for Cardiac Resynchronization Therapy (CRT)

Left Ventricular Synchronous Versus Sequential MultiSpot Pacing for CRT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02914457
Acronym
SYNSEQ
Enrollment
31
Registered
2016-09-26
Start date
2016-11-07
Completion date
2018-04-20
Last updated
2020-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The SYNSEQ study intends to assess the positive left ventricular dP/dt max achieved by MultiSpot LV pacing (either simultaneously or sequentially) in comparison to the response achieved by the current (standard) BiV pacing configuration in patients indicated/recommended for cardiac resynchronization therapy.

Detailed description

The following pacing configurations will be evaluated. Biventricular pacing (BiV): Pacing will be performed on one LV electrode pair, (at 3 different longitudinal locations), and on the tip of the RV-lead. In total, three different pacing BiV settings will be evaluated. Configuration 1: RV + LV lateral Apex, Configuration 2: RV + LV lateral Mid, Configuration 3: RV + LV lateral Base (Reference: Standard CRT) MultiSpot simultaneous LV-ventricular pacing (MultiSpot-SYN): Pacing will be performed on 3 electrodes on the LV wall, placed at different longitudinal locations, and on the tip of the RV-lead simultaneously. Configuration 4: RV + LV lateral Apex + LV lateral Mid + LV lateral Base MultiSpot sequential LV-ventricular pacing (MultiSpot-SEQ): 3 electrodes on the LV wall will be paced sequentially. The RV electrode will be paced simultaneously with last paced LV electrode.The timing-sequence and the amount of spots will depend on the electrical delays measured during the experiments. Configuration 5: LV lateral Apex =\> LV lateral Mid =\> LV lateral Base + RV

Interventions

Subjects will receive pacing from one right ventricular lead and one left ventricular catheter/lead with multiple LV pacing spots during electrophysiological study procedure.

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is indicated or recommended for CRT-P or CRT-D device according to current applicable ESC/AHA guidelines * Subject is in sinus rhythm * Subject receives optimal heart failure oral medical therapy * Subject is willing to sign the informed consent form * Subject is 18 years or older

Exclusion criteria

* Subject has permanent atrial fibrillation/flutter or tachycardia * Subject has pure right bundle branch block (= no additional left ventricular conduction delays) * Subject has left bundle branch block and QRS-duration of \> 150 ms and no sign of myocardial scar indicated by late gadolinium enhancement MRI * Subject experienced recent myocardial infarction, within 40 days prior to enrollment * Subject underwent valve surgery, within 90 days prior to enrollment * Subject is post heart transplantation, or is actively listed on the transplantation list * Subject is implanted with a left ventricular assist device * Subject has severe renal disease (up to physicians discretion) * Subject is on continuous or uninterrupted infusion (inotropic) therapy for heart failure (≥ 2 stable infusions per week) * Subject has severe aortic stenosis (with a valve area of \<1.0 cm2 or significant valve disease expected to be operated within study period) * Subject has complex and uncorrected congenital heart disease * Subject has a mechanical heart valve * Pregnant or breastfeeding women, or women of child bearing potential and who are not on a reliable form of birth control * Subject is enrolled in another study that could confound the results of this study, without documented pre-approval from Medtronic study manager

Design outcomes

Primary

MeasureTime frameDescription
Percentage Change in Positive Left Ventricular dP/dt Max (mmHG/Sec)Participants were followed for the time of the EP procedure, which had a median duration of 48 minLV dP/dt max is a measurement of the initial velocity of myocardial contraction and is derivative of the LV-pressure. The percentage changes correspond to a percentage change between a pacing configuration (pacing on, e.g., Multispot pacing) and baseline (LV pacing off). There are several repetitions of pacing off and on for each pacing configuration. For one repetition, the percentage change is determined as (\[median dP/dt max during pacing On\] - (median baseline dP/dt max during pacing Off\])/\[median dP/dt max during pacing Off\]. From all percentage changes for a given pacing configuration and subject, a regression analysis is performed to determine the regression predicted highest percentage change. The presented percentage change is the average over all subjects.

Secondary

MeasureTime frameDescription
Correlation Between Percentage Change LV dP/dt Max and Percentage Change Blood PressureParticipants were followed for the time of the EP procedure, which had a median duration of 48 minMeasured by invasive arterial blood line connected to a sensitive membrane displacement sensor. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were collected.The percentage changes correspond to a percentage change between a pacing configuration (pacing on, e.g., Multispot pacing) and baseline (LV pacing off). There are several repetitions of pacing off and on for each pacing configuration. For one repetition, the percentage change is determined as (\[median pressure during pacing On\] - (median pressure during pacing Off\])/\[median pressure during pacing Off\]. Correlation will be summarized over all pacing configurations and time points since the interest is in the overall correlation between LV dP/dt max and other measurements, not in the correlation per pacing configuration or per time point. The general linear model as described in Blank & Altman, Biometrical Journal 310 (1995), p 446, was used to determine the correlation.
Correlation Between Percentage Change LV dP/dt Max and Percentage Change Non-Invasive Blood PressureParticipants were followed for the time of the EP procedure, which had a median duration of 48 minAcquired through finger volume clamp
Correlation Between Percentage Change LV dP/dt Max and Q-LV RatioParticipants were followed for the time of the EP procedure, which had a median duration of 48 minDerived from intra-cardiac leads (invasive) and surface electrodes (non-invasive) respectively. The Q-LV interval is defined as the time from the onset of the QRS width of the surface ECG to the first large positive or negative peak of the LV electrogram (EGM) during a cardiac cycle. The Q-LV ratio will be calculated as Q-LV/QRS duration. Correlation will be summarized over all pacing configurations since the interest is in the overall correlation between LV dP/dt max and other measurements, not in the correlation per pacing configuration. The general linear model as described in Blank & Altman, Biometrical Journal 310 (1995), p 446, was used to determine the correlation between % change LV dP/dt max and Q-LV ratio.
Correlation Between Percentage Change LV dP/dt Max and % Change QRS WidthParticipants were followed for the time of the EP procedure, which had a median duration of 48 minDerived from surface electrodes (non-invasive). The percentage change is determined as (\[QRS width during pacing On\] - (QRS width during pacing Off\])/\[QRS width during pacing Off\]. The correlation between % change LV dP/dt max and % change QRS width will be summarized over all pacing configurations since the interest is in the overall correlation between LV dP/dt max and other measurements, not in the correlation per pacing configuration or per time point. The general linear model as described in Blank & Altman, Biometrical Journal 310 (1995), p 446, was used to determine the correlation.

Countries

Poland, Slovakia, Spain, Sweden, United Kingdom

Participant flow

Participants by arm

ArmCount
Electrophysiological Study
Subjects will receive pacing from one right ventricular lead and one left ventricular catheter/lead with multiple LV pacing spots during electrophysiological study procedure. Electrophysiological Study: Subjects will receive pacing from one right ventricular lead and one left ventricular catheter/lead with multiple LV pacing spots during electrophysiological study procedure.
30
Total30

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyECG acquisition error due to sweating1
Overall StudyElectrical instability of patient1
Overall StudyNo veins available for lead placement1
Overall StudyPhysician Decision1
Overall StudyProtocol Violation1
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicElectrophysiological Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
19 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
Age, Continuous66.4 years
STANDARD_DEVIATION 11.5
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Poland
21 participants
Region of Enrollment
Spain
2 participants
Region of Enrollment
Sweden
1 participants
Region of Enrollment
United Kingdom
6 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
25 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 31
other
Total, other adverse events
2 / 31
serious
Total, serious adverse events
3 / 31

Outcome results

Primary

Percentage Change in Positive Left Ventricular dP/dt Max (mmHG/Sec)

LV dP/dt max is a measurement of the initial velocity of myocardial contraction and is derivative of the LV-pressure. The percentage changes correspond to a percentage change between a pacing configuration (pacing on, e.g., Multispot pacing) and baseline (LV pacing off). There are several repetitions of pacing off and on for each pacing configuration. For one repetition, the percentage change is determined as (\[median dP/dt max during pacing On\] - (median baseline dP/dt max during pacing Off\])/\[median dP/dt max during pacing Off\]. From all percentage changes for a given pacing configuration and subject, a regression analysis is performed to determine the regression predicted highest percentage change. The presented percentage change is the average over all subjects.

Time frame: Participants were followed for the time of the EP procedure, which had a median duration of 48 min

Population: The analysis population contains all subjects who completed electrophysiological study with analyzable data. For some patients not all pacing configurations were applied. Two patients missed Multispot sequential pacing and one patient missed BiV mid pacing.

ArmMeasureGroupValue (MEAN)Dispersion
Electrophysiological StudyPercentage Change in Positive Left Ventricular dP/dt Max (mmHG/Sec)BiV apical10.59 % change LV dP/dt maxStandard Error 2.56
Electrophysiological StudyPercentage Change in Positive Left Ventricular dP/dt Max (mmHG/Sec)BiV mid12.20 % change LV dP/dt maxStandard Error 2.06
Electrophysiological StudyPercentage Change in Positive Left Ventricular dP/dt Max (mmHG/Sec)BiV basal11.51 % change LV dP/dt maxStandard Error 2.15
Electrophysiological StudyPercentage Change in Positive Left Ventricular dP/dt Max (mmHG/Sec)Multispot simultaneous15.64 % change LV dP/dt maxStandard Error 3.31
Electrophysiological StudyPercentage Change in Positive Left Ventricular dP/dt Max (mmHG/Sec)Multispot sequential11.80 % change LV dP/dt maxStandard Error 2.03
Secondary

Correlation Between Percentage Change LV dP/dt Max and % Change QRS Width

Derived from surface electrodes (non-invasive). The percentage change is determined as (\[QRS width during pacing On\] - (QRS width during pacing Off\])/\[QRS width during pacing Off\]. The correlation between % change LV dP/dt max and % change QRS width will be summarized over all pacing configurations since the interest is in the overall correlation between LV dP/dt max and other measurements, not in the correlation per pacing configuration or per time point. The general linear model as described in Blank & Altman, Biometrical Journal 310 (1995), p 446, was used to determine the correlation.

Time frame: Participants were followed for the time of the EP procedure, which had a median duration of 48 min

Population: The analysis population contains all subjects who completed electrophysiological study with analyzable data. For one patient no QRS width was available for analysis.

ArmMeasureValue (NUMBER)
Electrophysiological StudyCorrelation Between Percentage Change LV dP/dt Max and % Change QRS Width-0.28 Correlation coefficient
Secondary

Correlation Between Percentage Change LV dP/dt Max and Percentage Change Blood Pressure

Measured by invasive arterial blood line connected to a sensitive membrane displacement sensor. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were collected.The percentage changes correspond to a percentage change between a pacing configuration (pacing on, e.g., Multispot pacing) and baseline (LV pacing off). There are several repetitions of pacing off and on for each pacing configuration. For one repetition, the percentage change is determined as (\[median pressure during pacing On\] - (median pressure during pacing Off\])/\[median pressure during pacing Off\]. Correlation will be summarized over all pacing configurations and time points since the interest is in the overall correlation between LV dP/dt max and other measurements, not in the correlation per pacing configuration or per time point. The general linear model as described in Blank & Altman, Biometrical Journal 310 (1995), p 446, was used to determine the correlation.

Time frame: Participants were followed for the time of the EP procedure, which had a median duration of 48 min

Population: All patients with analyzable LV dP/dt max data and analyzable and/or available blood pressure data. Two patients of the 25 patients with analyzable LV dP/dt max data did not have blood pressure data available or analyzable.

ArmMeasureGroupValue (NUMBER)
Electrophysiological StudyCorrelation Between Percentage Change LV dP/dt Max and Percentage Change Blood PressureCorrelation between % change LV dP/dt max and SBP0.52 Correlation coefficient
Electrophysiological StudyCorrelation Between Percentage Change LV dP/dt Max and Percentage Change Blood PressureCorrelation between % change LV dP/dt max and DBP0.37 Correlation coefficient
Secondary

Correlation Between Percentage Change LV dP/dt Max and Percentage Change Non-Invasive Blood Pressure

Acquired through finger volume clamp

Time frame: Participants were followed for the time of the EP procedure, which had a median duration of 48 min

Population: The collection of non-invasive blood pressures was optional. During study execution, it was decided to not collect and/or analyze any non-invasive blood pressures.

Secondary

Correlation Between Percentage Change LV dP/dt Max and Q-LV Ratio

Derived from intra-cardiac leads (invasive) and surface electrodes (non-invasive) respectively. The Q-LV interval is defined as the time from the onset of the QRS width of the surface ECG to the first large positive or negative peak of the LV electrogram (EGM) during a cardiac cycle. The Q-LV ratio will be calculated as Q-LV/QRS duration. Correlation will be summarized over all pacing configurations since the interest is in the overall correlation between LV dP/dt max and other measurements, not in the correlation per pacing configuration. The general linear model as described in Blank & Altman, Biometrical Journal 310 (1995), p 446, was used to determine the correlation between % change LV dP/dt max and Q-LV ratio.

Time frame: Participants were followed for the time of the EP procedure, which had a median duration of 48 min

Population: The analysis population contains all subjects who completed electrophysiological study with analyzable data. For five patients no Q-LV timings were available for analysis.

ArmMeasureValue (NUMBER)
Electrophysiological StudyCorrelation Between Percentage Change LV dP/dt Max and Q-LV Ratio0.20 Correlation coefficient

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026